Breaking News

Theranos' Elizabeth Holmes banned from government health programs

January 19, 2024
Theranos founder Elizabeth Holmes was sentenced in November 2022 to 11 years in prison.
Justin Sullivan/Getty Images

Feds bar Theranos founder Elizabeth Holmes from government health programs

The Health and Human Services Department can exclude anyone convicted of a felony from Medicare, Medicaid, and Pentagon health programs.

By Sarah Owermohle


STAT+ | Opinion: The necessary roughness of 2023 has set up a very promising 2024 for biotech jobs

A partner at an executive search firm writes that his recent JPM24 experience is making him optimistic about the year ahead in biotech jobs.

By Christopher Palatucci


STAT+ | Hospitals offer their custom-built tech for sale in search of new revenue streams

Large health systems like Mayo Clinic and Mass General Brigham are looking for new revenue streams by licensing out custom-built tech tools.

By Mohana Ravindranath



Law enforcement vehicles sit on the freeway as pro-Palestinian protesters block Interstate 5 northbound on Jan. 6 in downtown Seattle.
Lindsey Wasson/AP

Opinion: Clogged arteries: the unseen cost of road-blocking protests

Mere minutes matter in medical emergencies, and real harms can result when ambulances are unable to reach people who need care.

By Christopher M. Worsham and Anupam B. Jena


STAT+ | The FDA's diagnostics chief, who led through Covid, has retired

Timothy Stenzel, who led the FDA's diagnostics division during the Covid-19 pandemic, has left the agency. He retired at the end of 2023.

By Lizzy Lawrence


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments